FDA Inspection 1009640 — Beth Israel Deaconess Medical Center
The FDA completed an inspection of Beth Israel Deaconess Medical Center on Apr 19, 2017 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 19, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Boston, MA (United States)